Modern Immunotherapy of Adult B-Lineage Acute Lymphoblastic Leukemia with Monoclonal Antibodies and Chimeric Antigen Receptor Modified T Cells

The introduction of newer cytotoxic monoclonal antibodies and chimeric antigen receptor modified T cells is opening a new age in the management of B-lineage adult acute lymphoblastic leukemia. This therapeutic change must be very positively acknowledged because of the limits of intensive chemotherap...

Descripción completa

Detalles Bibliográficos
Autores principales: Maino, Elena, Scattolin, Anna Maria, Viero, Piera, Sancetta, Rosaria, Pascarella, Anna, Vespignani, Michele, Bassan, Renato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283921/
https://www.ncbi.nlm.nih.gov/pubmed/25574360
http://dx.doi.org/10.4084/MJHID.2015.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283921/
https://www.ncbi.nlm.nih.gov/pubmed/25574360
http://dx.doi.org/10.4084/MJHID.2015.001

Ejemplares similares